Al Dahir Community celebrates surgical integration milestone at Burjeel Day Surgery Center
The celebration took place in the presence of H.E. Dr. Sultan Al Neyadi, UAE Astronaut and Minister of State for Youth Affairs. His participation emphasized the alignment of BDSC's services with the UAE's vision for an accessible and connected healthcare ecosystem. During the event, local community leaders shared personal experiences and praised the impact of the center in improving access to quality care. Senior leadership from Burjeel Holdings, including Dr. Shamsheer Vayalil, Founder and Chairman; Mr. John Sunil, CEO; and Mr. Omran Al Khoori, Member of the Board of Directors, also graced the occasion.
The gathering also marked the inauguration of the second phase of BDSC's Operating Theaters. This expansion reflects the center's commitment to enhancing the quality and efficiency of healthcare services provided to citizens and residents of Al Ain, particularly the local communities in and around the Al Dhahir area. With this development, the facility is now fully equipped and operational for performing a wide range of surgical procedures.
'This milestone reflects our commitment to building healthcare systems around the needs of people and communities. The successful integration of surgical services at BDSC will enhance the offerings for the community. We are proud of the opportunity to work in line with the vision of our leadership to improve healthcare experiences across Al Ain,' said Dr. Aysha Almahri, CEO, Al Ain Region, Burjeel Holdings.
Since its inception in May 2024, BDSC has evolved into a comprehensive surgical facility, offering a range of day surgeries across key specialties. From diagnostics to surgical interventions, the center now delivers a full suite of services, minimizing the need for patients to travel long distances for care. It offers specialized services in Orthopedics, ENT, General Surgery, Urology, Gynecology, Endoscopic Surgery, and more. The surgical unit is supported by board-certified doctors, rehabilitation experts, and modern diagnostic technology, and complex cases continue to be referred through Burjeel's broader network, ensuring seamless continuity of care.
'Our enhanced capabilities mean patients can now receive the care they need, quickly, safely, and close to home. We are proud to be a trusted partner for the community and will continue expanding services in response to local needs,' said Dr. Mohamed Hassan Abbass Hassan Elshamsy, Medical Director and Consultant in Ophthalmology at BDSC, Al Dhahir.
The event also served as a platform to reinforce future plans to expand services at the center, including the potential addition of emergency and more complex care offerings.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
3 hours ago
- Al Etihad
Burjeel Holdings reports 129% surge in Q2 profit
6 Aug 2025 20:41 A. SREENIVASA REDDY (ABU DHABI) Burjeel Holdings recorded a sharp 128.9% year-on-year surge in second-quarter net profit to Dh148 million, driven by strong revenue growth, improved patient yield, and operational efficiencies across its expanding healthcare in Q2 2025 rose 18.7% to Dh1.4 billion, while EBITDA jumped 59.4% to Dh306 million, reflecting stronger margins and the benefits of asset optimisation. The quarterly performance significantly boosted the group's first-half results, with net profit for H1 reaching Dh187 million — up 10.6% from Dh169 million in the same period last revenue rose 12.2% to Dh2.68 billion, supported by sustained demand for complex care services and expansion across key specialties. EBITDA for H1 stood at Dh487 million, marking a 14.2% increase over the prior robust performance was underpinned by a 12% increase in patient footfall in Q2. Across the first half, total patient visits rose to 3.4 million, with outpatient numbers up 8.6% to 3.28 million and inpatient footfall climbing 14.6% to 88,000. The Group also performed nearly 23,000 surgeries in Q2, representing an 18.7% annual increase, while bed occupancy improved to 69% from 65% in the year-ago quarter.'The second quarter delivered exceptionally strong results, with 19% revenue growth driven by a 12% increase in patient footfall and improved yield. EBITDA rose by 59%, accompanied by a margin uplift to 22%,' said CEO John Sunil.'These results reflect tangible progress in key operational areas such as physician manpower optimisation, formulary management, and cost control, while our strategic focus on super-specialty care is beginning to yield measurable benefits, enhancing both revenue and profitability,' he added. Sunil said the Group's oncology platform is now the UAE's largest private network and highlighted the growth in services related to transplants, fertility, mental health, and diagnostics. He reaffirmed Burjeel's focus on converting recent investments into sustained expansion and margin improvement. Source: Aletihad - Abu Dhabi
The National
4 hours ago
- The National
Sheikh Mohammed bin Rashid greeted by robot guest at Dubai gathering
Sheikh Mohammed bin Rashid, Vice President and Ruler of Dubai, was given a glimpse into the emirate's high-tech future when he was introduced to a robot guest at a gathering in Union House. The robot waved to dignitaries, ministers, investors and business leaders in video taken by Dubai Media Office on Wednesday. The machine then strode over to greet Sheikh Mohammed and guests including Dr Anwar Gargash, diplomatic adviser to President Sheikh Mohamed, at the Mudaif Majlis. The demonstration highlights the UAE's commitment to harnessing rapidly evolving technology, from drone delivery services to robot-assisted surgery in hospitals. In January, a robot concierge was put to work at a hotel on Saadiyat Island to test how technology could take on day-to-day tasks. The Type 1 Autodroid developed by Autogo, a division of UAE tech company Kintsugi, successfully completed the month-long trial at the St Regis Saadiyat Island Resort. It provided an early indicator of how humanoid machines could support people at work, or take over some menial tasks. Surgeons at Abu Dhabi's Sheikh Shakhbout Medical City first conducted surgery with the help of robotics in 2020. It was used to perform a pyeloplasty on a young Emirati. The procedure was to remove a 'ureteropelvic junction obstruction' – a blockage of the tube that carries urine from the kidneys to the bladder. 'The instruments used in robotic surgery provide surgeons with magnified, 3D high-definition vision, more comfortable use of instruments and easier access to areas that would've been difficult to reach using conventional methods,' Dr Sarfraz Ahmad, who led the team at SSMC, said at the time.
Zawya
4 hours ago
- Zawya
Saudi: Fakeeh group delivers H1 2025 revenue of $402.4mln, up 13% year-on-year
Dr Soliman Abdel Kader Fakeeh Hospital Company and its Subsidiaries ('Fakeeh Care Group', 'FCG', 'Fakeeh Care', the 'Company' or the 'Group'), a leading fully integrated academic healthcare provider listed on TASI (SYMBOL: 4017 and ISIN code SA562GSHUOH7), announced its financial results[1] for the second quarter ended 30 June 2025. Growth during the quarter was supported by higher patient volumes and a richer case‑mix as activity normalized post‑Ramadan. The total number of patients served reached 465 thousand+ in 2Q‑2025 (+16% YoY), taking 1H‑2025 volumes to ~900 thousand (+8% YoY). Outpatient and inpatient volumes grew 15% and 16%, respectively, in the quarter translating into combined revenue growth of 18%. Pricing and case‑mix tailwinds added support to the average revenue per outpatient visit and inpatient admission contributing 3% YTD on a consolidated revenue level. Jeddah's double‑digit growth was central driver, complemented by accelerating throughput in Riyadh and early activity in Madinah. At the headline level, the Group delivered 2Q‑2025 revenue of SR812 million (+24% YoY) and Net Profit after Zakat of SR68 million (+59% YoY); 1H‑2025 revenue was SR1.51 billion (+13% YoY). Commenting on the Group's performance, FCG's President Dr. Mazen Soliman Fakeeh said: 'In the second quarter of the year, Fakeeh Care Group revenues reached to SR812 million, posting a solid 24% year on year growth thanks to a 16% year‑on‑year growth of patients served and a richer case mix. Jeddah's year-on-year expansion in census and revenue continues to demonstrate the strength of our brand and clinical depth, while Riyadh's disciplined ramp‑up continues to progress—together with the recently opened DSFH Madinah—our geographic reach continues to broaden. Our platform remained a robust earnings engine with Attributable to Shareholders profits reaching SR154 million in the first half (SR82M in 2Q25) or 28% up year-on-year, after absorbing the anticipated start‑up operating losses from ramping facilities —investments that are underpinning our multi‑year growth trajectory. In Riyadh, operational beds increased to 102 (from 71 a year earlier), supporting mid‑30% growth in outpatient and inpatient volumes and a sharp rise in surgical throughput as higher‑complexity services scale. In Madinah, the Group admitted its first patients in the initial 48 beds (of 200 beds) under a disciplined, quality‑first ramp that is expected to build steadily. In Jeddah, the flagship network remained the primary revenue center, sustaining double‑digit volume growth and strong pull‑through across service lines. The Group broke ground on DSFMC Al Zahraa in Jeddah—developed in partnership with Yasser Yousef Naghi Investment Company—a key spoke in the hub‑and‑spoke strategy. The center will bring comprehensive, high‑quality care closer to the community via one‑day surgical suites, a 24/7 emergency department, an integrated diagnostic hub, and key medical specializations. Dr. Mazen Soliman Fakeeh added: 'Our integrated ecosystem—with tertiary hospitals, medical centers, home healthcare, emergency medical services, medical education, technology and retail medical offerings that complete our service continuum—continues to differentiate Fakeeh Care. We continue to invest in our digital infrastructure, embedding tools that optimize patient journeys, enhance resource utilization, and reinforce our value-based care model, elevating patient reported outcomes.' 'Looking ahead, our priorities are clear: drive utilization across our ramping facilities with strategic case mix refinement in Jeddah and Riyadh; execute a disciplined, quality first ramp in Madinah; advance milestones across our growth agenda; and continue embedding digital and data driven workflows that unlock efficiency while elevating care standards. We aim to further broaden our preventative medicine and early intervention offerings, strengthening longitudinal patient engagement. Throughout, we remain disciplined in capital deployment—preserving a conservative balance sheet as we fund expansion and cement the foundation for a highly scalable and sustainably profitable healthcare ecosystem. With a resilient mature platform, a scalable operating model, and a deepening role in the Kingdom's healthcare transformation, we are well positioned to create enduring value for patients, staff, students, shareholders and the broader community.' he concluded. During the quarter, the Group achieved JCI Enterprise Accreditation, becoming the first private healthcare group in the Kingdom to earn system‑wide endorsement—validating governance, safety culture, standardized clinical pathways and enterprise risk systems, and ensuring the quality DNA of the flagship facilities scales consistently as the network grows. In parallel, Fakeeh Emergency Medical Services (MedE) supported the Kingdom's Hajj operations through the mobilization of ambulatory teams and ambulances and the CSR operation of Namira Hospital at peak demand, deepening the Group's partnership with national health authorities and reinforcing its role in serving broader societal needs. Fakeeh Care Group's complete 2Q-2025 Earnings Release with management's analysis of the Company's performance is available for download on © Copyright 2022 The Saudi Gazette. All Rights Reserved. Provided by SyndiGate Media Inc. (
